LI; Zihai

Patent Applications and Registrations

Patent applications and USPTO patent grants for LI; Zihai.The latest application filed is for "methods for treatment and diagnosis of cancer by targeting glycoprotein a repetitions predominant (garp) and for providing effective immunotherapy alone or in combination".

Company Profile

0.5.11

LI; Zihai - Mount Pleasant SC
LI; Zihai - Charleston SC
Li; Zihai - Avon CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods For Treatment And Diagnosis Of Cancer By Targeting Glycoprotein A Repetitions Predominant (garp) And For Providing Effective Immunotherapy Alone Or In Combination App 20210292433 - LI; Zihai	2021-09-23
Methods for treatment and diagnosis of cancer by targeting glycoprotein A repetitions predominant (GARP) and for providing effective immunotherapy alone or in combination Grant 11,046,782 - Li June 29, 2	2021-06-29
Blocking Garp Cleavage And Methods Of Use Thereof App 20210087240 - LI; Zihai	2021-03-25
Methods For Treatment And Diagnosis Of Cancer By Targeting Glycoprotein A Repetitions Predominant (garp) And For Providing Effective Immunotherapy Alone Or In Combination App 20190127483 - LI; Zihai	2019-05-02
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality Grant 9,248,172 - Srivastava , et al. February 2, 2	2016-02-02
Chaperone-based Integrin Inhibitors For The Treatment Of Cancer And Inflammatory Diseases App 20140349944 - LI; Zihai ; et al.	2014-11-27
Using Heat Shock Proteins To Improve The Therapeutic Benefit Of A Non-vaccine Treatment Modality App 20140107391 - Srivastava; Pramod K. ; et al.	2014-04-17
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality Grant 8,591,890 - Srivastava , et al. November 26, 2	2013-11-26
Using Heat Shock Proteins To Improve The Therapeutic Benefit Of A Non-vaccine Treatment Modality App 20120021996 - Srivastava; Pramod K. ; et al.	2012-01-26
Using Heat Shock Proteins To Improve The Therapeutic Benefit Of A Non-vaccine Treatment Modality App 20120021997 - Srivastava; Pramod K. ; et al.	2012-01-26
Using Heat Shock Proteins To Improve The Therapeutic Benefit Of A Non-vaccine Treatment Modality App 20090208524 - Srivastava; Pramod K. ; et al.	2009-08-20
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality App 20060079458 - Srivastava; Pramod K. ; et al.	2006-04-13
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality Grant 6,984,389 - Li January 10, 2	2006-01-10
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality App 20030203846 - Srivastava, Pramod K. ; et al.	2003-10-30

Company Registrations

NCAGE Code	4E5H9	LI ZIHAI
CAGE Code	4E5H9	LI, ZIHAI
DUNS	624084302	LI, ZIHAI

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.